Common RNA Modification Linked to ALS Neurodegeneration
Scientists studied the m6A RNA modification finding that it is pivotal in TDP-43-related neurodegeneration in ALS.
Category: ALS
ALS
Latest
ALS
Latest
Protein-Based Treatment Therapy Shows Promise for People with ALS
Study reveals pathway that could enhance the survival of cells and prevent further vascular damage in people with ALS.
ALS
Latest
Stem Cell and Gene Therapy Shows Promise in ALS Safety Trial
Cedars-Sinai investigators confirm the safety of a novel stem cell and gene therapy targeting motor neurons that die in patients with ALS.
ALS May Be Linked to Both the Immune and Central Nervous Systems
The immune system may play a fundamental role along with the central nervous system in ALS, Mount Sinai researchers report.
Read More
Muscle Biopsy Test for Biomarker Could Lead to Earlier Diagnosis of ALS
In JAMA Neurology, researchers outline preliminary research that could pave the way for a future test for earlier diagnosis of ALS.
Read More
Relationship Between ALS Disease Patterns, Microscopic Changes in Brain, Spinal Cord Identified
Researchers have identified a relationship between the patterns of ALS symptoms and microscopic changes in the brain and spinal cord.
Read More
Stealth BioTherapeutics Presents ALS Therapy Data at Keystone Neurodegeneration Symposium
Stealth BioTherapeutics Corp presents SBT-272 preclinical data demonstrating improvement in upper neuron function in ALS.
Read More
Muscular Dystrophy Association Celebrates Lou Gehrig Day at Major League Baseball Games in June
The Muscular Dystrophy Association will honor Major League Baseball’s recognition of Lou Gehrig Day at games across the country in June.
Read More
Team Gleason Partners with Synchron to Redefine Accessibility
Team Gleason and Synchron announce a partnership agreement to provide patient-focused feedback on their platform to transform daily life.
Read More
n-Lorem Foundation and Columbia University Establish Silence ALS Initiative
Silence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients.
Read More
ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for ALS
ProMIS Neurosciences Inc announces new milestones in potential therapeutic approaches for ALS, the company notes in a media release.
Read More
Target ALS Names Winner of Rebecca Luker Courage Award
Target ALS announces Merit E. Cudkowicz as the winner of the first annual Target ALS Rebecca Luker Courage Award.
Read More
Muscular Dystrophy Association Accelerates Research, Advances Care, and Advocates to End ALS
MDA announces programming and events in support of people living with ALS throughout ALS Awareness Month in May.
Read More
Mutations in Noncoding DNA Protect the Brain from ALS
Weizmann Institute of Science researchers link a new gene to ALS that plays a defensive, rather than an offensive, role in the disease.
Read More
Researchers ID Potential ALS Treatment Window
Johns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities.
Read More
Study: Brain Implants Safe, May Help Those with Paralysis Use Computer for Daily Tasks
A brain-computer interface (aka brain implant) is safe and allows participants to use a computer to communicate by text and do daily tasks.
Read More
Hybrid Assistive Limb (HAL) Helps Improve Gait Ability in Patients with ALS
Professor Kano Osamu, MD, PhD, and his colleagues conducted a study to evaluate the effect of HAL-based training in ALS patients.
Read More
Is it Possible to Slow the Progression of Muscle Degeneration in ALS Patients?
Researchers from University of Arizona are investigating an oral drug candidate that may benefit patients with Lou Gehrig’s disease, or ALS.
Read More